US 9139525
N-oxide and/or di-N-oxide derivatives of dopamine receptor stabilizers/modulators displaying improved cardiovascular side-effects profiles
granted A61PA61P15/00A61P25/00
Quick answer
US patent 9139525 (N-oxide and/or di-N-oxide derivatives of dopamine receptor stabilizers/modulators displaying improved cardiovascular side-effects profiles) held by TEVA PHARMACEUTICALS INTERNATIONAL GMBH expires Mon Sep 17 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- TEVA PHARMACEUTICALS INTERNATIONAL GMBH
- Grant date
- Tue Sep 22 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 17 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 2
- CPC classes
- A61P, A61P15/00, A61P25/00, A61P25/02, A61P25/04